Back to Results
First PageMeta Content
WT1 / Immunology / Corixa / Cancer vaccine / Immunotherapy


Press Release GANYMED ANNOUNCES LICENSE OF WT1 IMMUNOTHERAPY RIGHTS BY CORIXA AND KIRIN Mainz, Germany / June 08, 2004 Ganymed Pharmaceuticals AG, Mainz, Germany, announced today that Corixa Corporation (Nasdaq: CRXA), U
Add to Reading List

Document Date: 2015-02-04 05:14:56

Open Document

File Size: 15,20 KB

Share Result on Facebook
UPDATE